Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.82 |
| ▸ | HPGD | P15428 | 3/20 | 0.82 |
| ▸ | POLB | P06746 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.74 |
| ▸ | RAB9A | P51151 | 7/20 | 0.67 |
| ▸ | NPC1 | O15118 | 6/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | CNR1 | P21554 | 1/20 | 0.58 |
| ▸ | CNR2 | P34972 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2228229 | 0.89 | HPGD (0.67) | SMN1; SMN2HPGDPOLBALDH1A1ALOX12 | |
| SCHEMBL14818759 | 0.88 | MAPK1 (0.74) | SMN1; SMN2HPGDPOLBALDH1A1ALOX12 | |
| SCHEMBL14688250 | 0.86 | HPGD (0.63) | SMN1; SMN2HPGDPOLBALDH1A1ALOX12 | |
| SCHEMBL11707705 | 0.85 | HPGD (0.62) | SMN1; SMN2HPGDPOLBALDH1A1ALOX12 | |
| SCHEMBL19579563 | 0.84 | SMN1; SMN2 (0.67) | SMN1; SMN2HPGDPOLBALDH1A1ALOX12 | |
| SCHEMBL13161962 | 0.84 | SMN1; SMN2 (0.60) | SMN1; SMN2HPGDPOLBALDH1A1ALOX12 | |
| SCHEMBL28574459 | 0.83 | ALDH1A1 (0.73) | SMN1; SMN2HPGDPOLBALDH1A1MEN1 | |
| SCHEMBL1849467 | 0.83 | MAPT (0.79) | SMN1; SMN2HPGDALDH1A1RAB9ANPC1 | |
| SCHEMBL1032002 | 0.83 | MAPK1 (0.77) | SMN1; SMN2HPGDALDH1A1MEN1KMT2A | |
| SCHEMBL29046318 | 0.83 | SMN1; SMN2 (0.58) | SMN1; SMN2HPGDPOLBALDH1A1ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12533339-B2 | Small molecule antiviral drug treatment for human papillomavirus infections | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2026-01-27 | — | — | US | disclosed |
| US-20240173291-A1 | SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS | THE TRUSTEES OF INDIANA UNIVERSITY | 2024-05-30 | — | — | US | disclosed |
| US-11877999-B2 | Small molecule antiviral drug treatment for human papillomavirus infections | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2024-01-23 | — | — | US | disclosed |
| US-11628158-B2 | Small molecule antiviral drug treatment for human papillomavirus infections | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2023-04-18 | — | — | US | disclosed |
| EP-4135698-A2 | SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS | The Trustees of Indiana University (US) | 2023-02-22 | — | — | EP | disclosed |
| US-20230047626-A1 | SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS | THE TRUSTEES OF INDIANA UNIVERSITY | 2023-02-16 | — | — | US | disclosed |
| US-20230047626-A1 | SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS | THE TRUSTEES OF INDIANA UNIVERSITY | 2023-02-16 | — | — | US | disclosed |
| US-20220142973-A1 | SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS | THE TRUSTEES OF INDIANA UNIVERSITY | 2022-05-12 | — | — | US | disclosed |
| US-20220142973-A1 | SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS | THE TRUSTEES OF INDIANA UNIVERSITY | 2022-05-12 | — | — | US | disclosed |
| WO-2021212010-A2 | SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2021-10-21 | — | — | WO | disclosed |
| US-8304547-B2 | Azolecarboxamide compound or salt thereof | ASTELLAS PHARMA INC. (JP) | 2012-11-06 | — | — | US | disclosed |
| US-8304547-B2 | Azolecarboxamide compound or salt thereof | ASTELLAS PHARMA INC. (JP) | 2012-11-06 | — | — | US | disclosed |
| US-20100249088-A1 | AZOLECARBOXAMIDE COMPOUND OR SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2010-09-30 | — | — | US | disclosed |
| EP-2206707-A1 | AZOLECARBOXAMIDE COMPOUND OR SALT THEREOF | Astellas Pharma Inc. (JP) | 2010-07-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230047626-A1 | SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS | TP53, EIF2AK2, POLI | SMN1; SMN2 4022/4885HPGD 962/4885POLB 30/4885 |
| US-11877999-B2 | Small molecule antiviral drug treatment for human papillomavirus infections | TP53, EIF2AK2, POLI | SMN1; SMN2 4022/4885HPGD 962/4885POLB 30/4885 |
| US-20220142973-A1 | SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS | TP53, EIF2AK2, POLI | SMN1; SMN2 4022/4885HPGD 962/4885POLB 30/4885 |
| US-12533339-B2 | Small molecule antiviral drug treatment for human papillomavirus infections | CCND3, CCND1, TPD52L2 | SMN1; SMN2 2804/4885HPGD 2488/4885POLB 424/4885 |
| US-20240173291-A1 | SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS | TP53, EIF2AK2, POLI | SMN1; SMN2 4022/4885HPGD 962/4885POLB 30/4885 |
| US-20100249088-A1 | AZOLECARBOXAMIDE COMPOUND OR SALT THEREOF | TRPV1, FGFR3, GPR17 | SMN1; SMN2 3213/4885HPGD 1224/4885POLB 4348/4885 |
| US-11628158-B2 | Small molecule antiviral drug treatment for human papillomavirus infections | TP53, EIF2AK2, POLI | SMN1; SMN2 4022/4885HPGD 962/4885POLB 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.